Biotech Values

[jq1234]

Inhibitex Announces Proposed Public Offering

[Who esle is going to raise money post EASL?]

ATLANTA--(BUSINESS WIRE)-- Inhibitex, Inc. (Nasdaq:INHX - News) today announced its intention, subject to market and other conditions, to commence a public offering of its common stock. The Company intends to use the net proceeds from the offering for working capital and general corporate purposes, including a Phase 2 clinical trial for INX-189, a nucleotide polymerase inhibitor that it is developing for the treatment of chronic hepatitis C infections, and research and development expenses related to its other development programs.



Deutsche Bank Securities Inc. is acting as sole book-running manager.


http://finance.yahoo.com/news/Inhibitex-Announces-Proposed-bw-3984028636.html?x=0&.v=1